CIK 0001853816
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Conversion Senior Vice President acquired 64,631 shares (conversion)
- 4 Open-market buy Director bought 35,714 shares
- 4 Conversion 10% owner acquired 1,988,227 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 8,163 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 4,581 shares (conversion)
- 4 Conversion Senior VP, Development acquired 2,439 shares (conversion)
- 4 Open-market buy President, CEO and Chairman bought 152,857 shares at $4.96 ($49,631)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 5 of 6 · 102 filings